Trials / Completed
CompletedNCT02099032
Milk Polar Lipids Consumption, Lipid Metabolism, and Inflammation in Menopausal Women
Influence of Milk Polar Lipids Intake on Lipid Metabolism, Body Composition, Inflammation and Intestinal Microbiota in Menopausal Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- Female
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
Polar lipids have a specific chemical structure: they are an essential component of human cell membranes, play a major role in the nervous system and also influence the metabolic pathways including the cholesterol metabolism. Polar lipids are used in food-processing industry for their emulsification properties. The most famous emulsifier is soya lecithin but milk also naturally contains natural emulsifiers such as polar lipids. The purpose of this research is to study plasma cholesterol variation after daily intake of milk polar lipids-fortified cheese products. The volunteers will have to consume 100 g of cheese product during four weeks instead of their usual cheese products. It is a bi-centric study with a centre in LYON (Centre de Recherche en Nutrition Humaine Rhône-Alpes) and CLERMONT-FERRAND (Centre de Recherche en Nutrition Humaine Auvergne).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | 3g milk polar lipid fortified cheese consumption | Women will have to consume daily 100g of a 3g milk polar lipid fortified cheese product instead of usual cheese products during four weeks. |
| OTHER | 5g milk polar lipid fortified cheese consumption | Women will have to consume daily 100g of a 5 g milk polar lipid fortified cheese product instead of usual cheese products during four weeks. |
| OTHER | Unfortified cheese product consumption | Women will have to consume daily 100g of a unfortified cheese product instead of usual cheese products during four weeks |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-03-28
- Last updated
- 2021-01-27
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02099032. Inclusion in this directory is not an endorsement.